S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?

Utah Medical Products - UTMD Stock Forecast, Price & News

$89.32
+0.57 (+0.64%)
(As of 01/27/2023 08:56 PM ET)
Add
Compare
Today's Range
$87.00
$91.38
50-Day Range
$88.16
$101.88
52-Week Range
$80.10
$109.50
Volume
7,500 shs
Average Volume
9,644 shs
Market Capitalization
$324.23 million
P/E Ratio
20.35
Dividend Yield
1.32%
Price Target
N/A

Utah Medical Products MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.77% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.92
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$18,190 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.71 out of 5 stars

Medical Sector

72nd out of 1,049 stocks

Surgical & Medical Instruments Industry

7th out of 105 stocks


UTMD stock logo

About Utah Medical Products (NASDAQ:UTMD) Stock

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

UTMD Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
UTMD Utah Medical Products, Inc.
Utah Medical Products Inc
Utah Medical Products Inc - Stock News
Utah Medical Products declares $0.29 dividend
See More Headlines
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

UTMD Company Calendar

Last Earnings
4/25/2019
Ex-Dividend for 1/4 Dividend
12/15/2022
Dividend Payable
1/04/2023
Today
1/30/2023
Next Earnings (Estimated)
2/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:UTMD
CUSIP
91748810
Employees
178
Year Founded
N/A

Profitability

Net Income
$14.79 million
Pretax Margin
39.23%

Debt

Sales & Book Value

Annual Sales
$49.05 million
Cash Flow
$6.15 per share
Book Value
$29.34 per share

Miscellaneous

Free Float
3,389,000
Market Cap
$324.23 million
Optionable
Not Optionable
Beta
0.22

Key Executives

  • Kevin Leighton Cornwell
    Chairman, President, CEO & Secretary
  • Brian Lee Koopman
    Chief Financial Officer & Controller
  • Paul Olson Richins
    Independent Director













UTMD Stock - Frequently Asked Questions

How have UTMD shares performed in 2023?

Utah Medical Products' stock was trading at $100.53 at the beginning of 2023. Since then, UTMD stock has decreased by 11.2% and is now trading at $89.32.
View the best growth stocks for 2023 here
.

When is Utah Medical Products' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 7th 2023.
View our UTMD earnings forecast
.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) released its quarterly earnings results on Thursday, April, 25th. The medical instruments supplier reported $0.84 earnings per share for the quarter. The medical instruments supplier earned $10.73 million during the quarter. Utah Medical Products had a trailing twelve-month return on equity of 14.86% and a net margin of 31.09%.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products announced a quarterly dividend on Tuesday, November 1st. Shareholders of record on Friday, December 16th will be given a dividend of $0.295 per share on Wednesday, January 4th. This represents a $1.18 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, December 15th. This is a boost from the stock's previous quarterly dividend of $0.29.
Read our dividend analysis for UTMD
.

Is Utah Medical Products a good dividend stock?

Utah Medical Products (NASDAQ:UTMD) pays an annual dividend of $1.18 per share and currently has a dividend yield of 1.32%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 26.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for UTMD.

What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO?

8 employees have rated Utah Medical Products Chief Executive Officer Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among the company's employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Rice Hall James & Associates LLC (3.15%), Cardinal Capital Management (0.31%) and Strs Ohio (0.16%). Insiders that own company stock include Barbara A Payne, Barbara A Payne, Ernst G Hoyer, Kevin L Cornwell and Paul O Richins.
View institutional ownership trends
.

How do I buy shares of Utah Medical Products?

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $89.32.

How much money does Utah Medical Products make?

Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $324.23 million and generates $49.05 million in revenue each year. The medical instruments supplier earns $14.79 million in net income (profit) each year or $4.39 on an earnings per share basis.

How many employees does Utah Medical Products have?

The company employs 178 workers across the globe.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The official website for the company is www.utahmed.com. The medical instruments supplier can be reached via phone at (801) 566-1200 or via fax at 801-566-7305.

This page (NASDAQ:UTMD) was last updated on 1/30/2023 by MarketBeat.com Staff